These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24510469)
21. Sibutramine-associated QT interval prolongation and cardiac arrest. Ernest D; Gershenzon A; Corallo CE; Nagappan R Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104 [TBL] [Abstract][Full Text] [Related]
22. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686 [TBL] [Abstract][Full Text] [Related]
23. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977 [TBL] [Abstract][Full Text] [Related]
24. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest. Kiblboeck D; Braeuer-Mocker M; Siostrzonek P; Reisinger J BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22927286 [No Abstract] [Full Text] [Related]
25. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331 [TBL] [Abstract][Full Text] [Related]
26. [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation]. Karch M; Schmitt C; Plewan A; Schmidt G; Schömig A Herz; 1997 Feb; 22(1):51-6. PubMed ID: 9173039 [TBL] [Abstract][Full Text] [Related]
27. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room]. Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213 [TBL] [Abstract][Full Text] [Related]
28. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide. Taylor R; Gandhi MM; Lloyd G BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811 [TBL] [Abstract][Full Text] [Related]
29. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. Shantsila E; Watson T; Lip GY Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322 [TBL] [Abstract][Full Text] [Related]
36. Short QT syndrome: pharmacological treatment. Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889 [TBL] [Abstract][Full Text] [Related]
37. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054 [TBL] [Abstract][Full Text] [Related]
38. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Khan IA; Gowda RM Int J Cardiol; 2004 May; 95(1):1-6. PubMed ID: 15159030 [TBL] [Abstract][Full Text] [Related]
39. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome. Hallman K; Carlsson L Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635 [TBL] [Abstract][Full Text] [Related]
40. A case of flecainide-induced hyponatremia. Ahmed M; Sra J; Akhtar M; Mortada ME J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1170-2. PubMed ID: 19298558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]